Description
IDIQ FOR BLOOD AND BLOOD PRODUCTS
First action · last action
2022-10-01 · 2023-12-26
Transactions
2
First transaction's obligation
$1,146,771
Base + all options value (sum of deltas)
$1,116,857
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C26121D0040
NAICS
621991 · BLOOD AND ORGAN BANKS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-10-01+$1,146,771= $1,146,771
- Mod P000012023-12-26-$29,914= $1,116,857
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-10-01 | +$1,146,771 | $1,146,771 | IDIQ FOR BLOOD AND BLOOD PRODUCTS |
| Mod P00001· FUNDING ONLY ACTION | 2023-12-26 | −$29,914 | $1,116,857 | IDIQ FOR BLOOD AND BLOOD PRODUCTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HJD6G4D6TJY5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26126P1095 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $39,172 | FY2026 |
| 36C24E26N0092 | RPO EAST (36C24E) · Q301 · REFERENCE LABORATORY TESTING | $8,136,000 | FY2026 |
| 36C26126D0025 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6506 · BLOOD AND BLOOD PRODUCTS | $0 | FY2026 |
| 36C26126N0339 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6506 · BLOOD AND BLOOD PRODUCTS | $400,000 | FY2026 |
| 36C26126C0001 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · H199 · QUALITY CONTROL- MISCELLANEOUS | $263,280 | FY2026 |
| 36C26126C0003 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · Q505 · MEDICAL- GASTROENTEROLOGY | $411,668 | FY2026 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26123N0036_3600_36C26121D0040_3600 · retrieved 2026-09-26.